General Information of the Compound
| Compound ID |
CP0549334
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3S,6S,14S)-6-acetamido-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-3-[(1R)-1-hydroxyethyl]-2,5,8-trioxo-1,4,9-triazacyclotetradecane-14-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H41N9O7S
|
||||||||||||||||||
| Molecular Weight |
659.77
|
||||||||||||||||||
| Canonical SMILES |
C[C@@H](O)[C@@H]1NC(=O)[C@H](CC(=O)NCCCC[C@H](NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)c1nc2ccccc2s1)NC(C)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H41N9O7S/c1-15(39)23-27(45)36-19(9-5-6-12-32-22(41)14-20(26(44)38-23)34-16(2)40)25(43)35-18(10-7-13-33-29(30)31)24(42)28-37-17-8-3-4-11-21(17)46-28/h3-4,8,11,15,18-20,23,39H,5-7,9-10,12-14H2,1-2H3,(H,32,41)(H,34,40)(H,35,43)(H,36,45)(H,38,44)(H4,30,31,33)/t15-,18+,19+,20+,23+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
QKWNZGZXTOQLON-WPUDHWPRSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound